Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standardized versus individualized growth hormone dosing in short children born small for gestational age
NL-OMON38571Phase 4Not yet recruiting
- Sponsor
- Dutch Growth Research Foundation
- Start
- Jan 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of somatropin in Short stature in children born small for gestational age (2 arms), sponsored by Dutch Growth Research Foundation. Primary endpoints: Adult height SDS and Non-inferiority in adult height SDS. Planned start Jan 2014; status: not yet recruiting.
02
Drugs
somatropin
03
Conditions
Short stature in children born small for gestational age
Beyond the preview
Go deeper on NL-OMON38571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38571.